Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.

Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.

John Foley is Reuters Breakingviews' Global Finance Editor. He has previously written and edited from London, Beijing and Hong Kong, and established Breakingviews’ first Asian bureau in 2009, ...

Breakingviews sets the agenda in global finance. With a keen eye on markets and current events, we deliver thoughtful, actionable insight and analysis.

Robyn Mak joined Reuters Breakingviews in 2013. Previously, she was a Research Associate for the Global Policy Programs at the Asia Society in New York. She has also worked at the Carnegie Endowment ...

Antony Currie joined Breakingviews when it opened its New York bureau in 2005, working there until moving to Melbourne, Australia in late 2020. He has covered everything from the car industry to ...

Katrina Hamlin is global production editor, based in Hong Kong. She is also a columnist, writing on topics including autos and electric vehicles, as well as the gambling industry in Macau and Asia.

Lauren Silva Laughlin was one of the original members of the U.S. Reuters Breakingviews office, which she joined in 2006. Two stints as an investment banker notwithstanding - and one as a high school ...

Jennifer Saba is a columnist covering media, Silicon Valley and Wall Street based in New York. She joined Breakingviews in 2015 from Reuters where she was a correspondent reporting on companies like ...

Chan Ka Sing is China Columnist for Reuters Breakingviews. Prior to joining Reuters, he worked at Week in China, Hong Kong Economic Journal and Dow Jones Newswires.

Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.

Robert Cyran, U.S. tech columnist, joined Breakingviews in London in 2003 and moved four years later to New York, where he continues to cover global technology, pharmaceuticals and special situations.